Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab

類似資料

• Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis
  著者:: Schäfer, Martin, 等
  出版事項: (2020)
• Corrigendum to: Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis
  著者:: Schäfer, Martin, 等
  出版事項: (2020)
• Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis
  著者:: Meissner, Yvette, 等
  出版事項: (2016)
• Long-term effectiveness of tocilizumab in patients with rheumatoid arthritis, stratified by number of previous treatment failures with biologic agents: results from the German RABBIT cohort
  著者:: Baganz, Lisa, 等
  出版事項: (2017)
• Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT
  著者:: Strangfeld, Anja, 等
  出版事項: (2010)